Submitted by Anonymous (not verified) on 20 October 2023 - 11:29
Opinion/decision on a Paediatric investigation plan (PIP): Tislelizumab, decision type: , therapeutic area: , PIP number: P/0142/2019
Source:
Opinion/decision on a Paediatric investigation plan (PIP): Tislelizumab, decision type: , therapeutic area: , PIP number: P/0142/2019